Survival of patients with head and neck cancer
β Scribed by F. Sadat; A. Wienke; J. Dunst; T. Kuhnt
- Publisher
- Springer
- Year
- 2011
- Tongue
- German
- Weight
- 631 KB
- Volume
- 188
- Category
- Article
- ISSN
- 0179-7158
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background The purpose of this study was to describe patient characteristics and prognostic factors for survival in the palliative stage of patients with head and neck cancer. ## Methods Since November 2003, all patients with palliative head and neck cancer treated in our hospital
## Background: In patients with head and neck squamous cell carcinoma (hnscc) the estimated prognosis is usually based on the tnm classification. the relative weight of the three contributing parameters is often not completely clear. moreover, the impact of other important clinical variables such a
A review of 164 patients with far advanced head and neck cancer, treated by a cytotoxic chemotherapy over a ten year period, at WAyne State University, Detroit, Michigan, was done in an attempt to determine factors that may influence the response to chemotherapy and subsequent survival. Response rat
## Abstract ## Background Chemoresponse is a significant outcome predictor in patients with head and neck cancer, regardless of the treatment modality used. The histoculture drug response assay (HDRA) has been shown to be a reliable method for in vitro chemoresponse assessment. In this study, we h
## Abstract ## Background. Although metaβanalysis showed that survival improved with concurrent chemoradiation in locally advanced head and neck cancer, neoadjuvant chemotherapy is still unique, because it renders curative surgery feasible for marginally resectable head and neck cancer patients.